Multi-center Clinical Study on Neonatal Hyperbilirubinemia
NCT ID: NCT03824990
Last Updated: 2021-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20000 participants
INTERVENTIONAL
2018-03-01
2021-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Before-intervention phase
All the healthy infants who were admitted from March 2018 to August 2018 to the Well Baby nurse of different hospitals.
No interventions assigned to this group
Intervention phase
All the healthy infants who were admitted from September 2018 to February 2019 to the Well Baby nurse of different hospitals.During this phase,multiple intervention bundles of quality improvement will be implemented.
Quality improvement of management of neonatal jaundice
During the Intervention phase and Sustainability phase ,The hospitals will receive training of multiple evidence based quality improvement methods.
Sustainability intervention phase
All the healthy infants who were admitted from March 2019 to August 2019 to the Well Baby nurse of different hospitals.In the Sustainability intervention phase,multiple intervention bundles of quality improvement will be continuous implemented.
Quality improvement of management of neonatal jaundice
During the Intervention phase and Sustainability phase ,The hospitals will receive training of multiple evidence based quality improvement methods.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quality improvement of management of neonatal jaundice
During the Intervention phase and Sustainability phase ,The hospitals will receive training of multiple evidence based quality improvement methods.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Day
28 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
JiLin Women and Children Health Hospital
UNKNOWN
Shandong Provincial Hospital
OTHER_GOV
Shan Dong Qian Fo Shan Hospital
UNKNOWN
Shan Dong Liao Cheng Hospital
UNKNOWN
Guangxi Maternal and Child Health Hospital
OTHER
Northwest Women's and Children's Hospital, Xi'an, Shaanxi
OTHER
Yin Chuan Maternity and Child Health Hospital
UNKNOWN
Nanjing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhangbin Yu
Nan Jing Maternity and Child Health Care Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shuping Han, PHD
Role: STUDY_DIRECTOR
Nanjing Maternity and Child Health Care Hospital
Zhangbin Yu, PHD
Role: PRINCIPAL_INVESTIGATOR
Nanjing Maternity and Child Health Care Hospital
Zhiyong Sun, PHD
Role: PRINCIPAL_INVESTIGATOR
JiLin Women and Children Health Hospital
Haiyan Cai, PHD
Role: PRINCIPAL_INVESTIGATOR
Qinhuangdao Maternal and Child Health Care Hospital
Yonghui Yu, MD
Role: PRINCIPAL_INVESTIGATOR
Shandong Provincial Hospital
Xin Yuan, MD
Role: PRINCIPAL_INVESTIGATOR
Shan Dong Qian Fo Shan Hospital
Jin Qian, MD
Role: PRINCIPAL_INVESTIGATOR
Shan Dong Liao Cheng Hospital
Jimei Wang, PHD
Role: PRINCIPAL_INVESTIGATOR
Obstetrics & Gynecology Hospital of Fudan University
Wenyan Tang, PHD
Role: PRINCIPAL_INVESTIGATOR
Jiangxi Maternal and Child Health Hospital
Qiufen Wei, PHD
Role: PRINCIPAL_INVESTIGATOR
Guangxi Maternal and Child Health Hospital
Zhankui Li, PHD
Role: PRINCIPAL_INVESTIGATOR
Northwest Women's and Children's Hospital, Xi'an, Shaanxi
Jie Gu, PHD
Role: PRINCIPAL_INVESTIGATOR
Yin Chuan Maternity and Child Health Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nanjing Maternity and Child Health Care Hospital
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NMU-FY2018-72
Identifier Type: -
Identifier Source: org_study_id